{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:30:15Z","timestamp":1793089815403,"version":"4.5.0"},"reference-count":39,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2024.14628","type":"journal-article","created":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T08:09:57Z","timestamp":1723536597000},"source":"Crossref","is-referenced-by-count":6,"title":["Hexokinase 2 as an independent risk factor for worse patient survival in esophageal adenocarcinoma and as a potential therapeutic target protein: A retrospective, single\u2011center cohort study"],"prefix":"10.3892","volume":"28","author":[{"given":"Su","family":"Lyu","sequence":"first","affiliation":[{"name":"Faculty of Medicine and University Hospital of Cologne, Institute of Pathology, University of Cologne, D\u201150937 Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Simon","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and University Hospital of Cologne, Institute of Pathology, University of Cologne, D\u201150937 Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-On","family":"Jung","sequence":"additional","affiliation":[{"name":"Department of General, Visceral and Cancer Surgery, Faculty of Medicine and University Hospital of Cologne, University of Cologne, D\u201150937 Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Fretter","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and University Hospital of Cologne, Institute of Pathology, University of Cologne, D\u201150937 Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Schr\u00f6der","sequence":"additional","affiliation":[{"name":"Department of General, Visceral and Cancer Surgery, Faculty of Medicine and University Hospital of Cologne, University of Cologne, D\u201150937 Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Bruns","sequence":"additional","affiliation":[{"name":"Department of General, Visceral and Cancer Surgery, Faculty of Medicine and University Hospital of Cologne, University of Cologne, D\u201150937 Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Schmidt","sequence":"additional","affiliation":[{"name":"Department of General, Visceral and Cancer Surgery, Faculty of Medicine and University Hospital of Cologne, University of Cologne, D\u201150937 Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Quaas","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and University Hospital of Cologne, Institute of Pathology, University of Cologne, D\u201150937 Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Knipper","sequence":"additional","affiliation":[{"name":"Department of General, Visceral and Cancer Surgery, Faculty of Medicine and University Hospital of Cologne, University of Cologne, D\u201150937 Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2024,8,13]]},"reference":[{"key":"key20240906090918_b1-ol-28-4-14628","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1007\/s10620-023-08126-6","article-title":"Population based time trends in the epidemiology and mortality of gastroesophageal junction and esophageal adenocarcinoma","volume":"69","author":"Agarwal","year":"2024","journal-title":"Dig Dis Sci"},{"key":"key20240906090918_b2-ol-28-4-14628","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"key20240906090918_b3-ol-28-4-14628","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/1476-4598-12-152","article-title":"Tumor glycolysis as a target for cancer therapy: Progress and prospects","volume":"12","author":"Ganapathy-Kanniappan","year":"2013","journal-title":"Mol Cancer"},{"key":"key20240906090918_b4-ol-28-4-14628","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s12032-014-0118-1","article-title":"Expression patterns of three regulation enzymes in glycolysis in esophageal squamous cell carcinoma: association with survival","volume":"31","author":"Li","year":"2014","journal-title":"Med Oncol"},{"key":"key20240906090918_b5-ol-28-4-14628","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.cbd.2007.11.002","article-title":"Molecular evolution of the vertebrate hexokinase gene family: Identification of a conserved fifth vertebrate hexokinase gene","volume":"3","author":"Irwin","year":"2008","journal-title":"Comp Biochem Physiol Part D Genomics Proteomics"},{"key":"key20240906090918_b6-ol-28-4-14628","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1242\/jeb.00241","article-title":"Isozymes of mammalian hexokinase: Structure, subcellular localization and metabolic function","volume":"206","author":"Wilson","year":"2003","journal-title":"J Exp Biol"},{"key":"key20240906090918_b7-ol-28-4-14628","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/B978-0-12-378630-2.00073-6","article-title":"Hexokinase\/glucokinase","volume-title":"Encyclopedia of Biological Chemistry","author":"Van Schaftingen","year":"2013"},{"key":"key20240906090918_b8-ol-28-4-14628","doi-asserted-by":"publisher","first-page":"6069","DOI":"10.1038\/ncomms7069","article-title":"Coordinated regulatory variation associated with gestational hyperglycaemia regulates expression of the novel hexokinase HKDC1","volume":"6","author":"Guo","year":"2015","journal-title":"Nat Commun"},{"key":"key20240906090918_b9-ol-28-4-14628","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0304-3835(94)90142-2","article-title":"Steady state transcript levels of the type II hexokinase and type 1 glucose transporter in human tumor cell lines","volume":"82","author":"Shinohara","year":"1994","journal-title":"Cancer Lett"},{"key":"key20240906090918_b10-ol-28-4-14628","doi-asserted-by":"publisher","first-page":"18807","DOI":"10.1038\/s41598-022-23598-8","article-title":"A pan-cancer analysis of the role of hexokinase II (HK2) in human tumors","volume":"12","author":"Li","year":"2022","journal-title":"Sci Rep"},{"key":"key20240906090918_b11-ol-28-4-14628","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1007\/s11605-011-1727-z","article-title":"Molecular mechanism underlying the detection of colorectal cancer by 18F-2-fluoro-2-deoxy-D-glucose positron emission tomography","volume":"16","author":"Izuishi","year":"2012","journal-title":"J Gastrointest Surg"},{"key":"key20240906090918_b12-ol-28-4-14628","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s12149-007-0076-1","article-title":"Clinicopathological presentation of varying 18F-FDG uptake and expression of glucose transporter 1 and hexokinase II in cases of hepatocellular carcinoma and cholangiocellular carcinoma","volume":"22","author":"Paudyal","year":"2008","journal-title":"Ann Nucl Med"},{"key":"key20240906090918_b13-ol-28-4-14628","doi-asserted-by":"publisher","first-page":"32332","DOI":"10.18632\/oncotarget.15974","article-title":"Poor prognosis of hexokinase 2 overexpression in solid tumors of digestive system: A meta-analysis","volume":"8","author":"Wu","year":"2017","journal-title":"Oncotarget"},{"key":"key20240906090918_b14-ol-28-4-14628","doi-asserted-by":"publisher","first-page":"3751","DOI":"10.1245\/s10434-014-3848-6","article-title":"Prognostic impact of clinicopathological features and expression of biomarkers related to (18)F-FDG uptake in esophageal cancer","volume":"21","author":"Schreurs","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"key20240906090918_b15-ol-28-4-14628","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"key":"key20240906090918_b16-ol-28-4-14628","article-title":"TNM atlas","author":"Rous","year":"2021","edition":"7th edition"},{"key":"key20240906090918_b17-ol-28-4-14628","doi-asserted-by":"publisher","first-page":"639","DOI":"10.3892\/mco.2017.1194","article-title":"Copy-number variation and protein expression of DOT1L in pancreatic adenocarcinoma as a potential drug target","volume":"6","author":"Loeser","year":"2017","journal-title":"Mol Clin Oncol"},{"key":"key20240906090918_b18-ol-28-4-14628","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.lungcan.2013.07.016","article-title":"Evaluation of EGFR protein expression by immunohistochemistry using H-score and the magnification rule: Re-analysis of the SATURN study","volume":"82","author":"Mazi\u00e8res","year":"2013","journal-title":"Lung Cancer"},{"key":"key20240906090918_b19-ol-28-4-14628","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3390\/cancers12020451","article-title":"Dickkopf-2 (DKK2) as context dependent factor in patients with esophageal adenocarcinoma","volume":"12","author":"Schiffmann","year":"2020","journal-title":"Cancers (Basel)"},{"key":"key20240906090918_b20-ol-28-4-14628","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1186\/s12885-023-11146-0","article-title":"High NANOG expression correlates with worse patients' survival in esophageal adenocarcinoma","volume":"23","author":"Knipper","year":"2023","journal-title":"BMC Cancer"},{"key":"key20240906090918_b21-ol-28-4-14628","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.3390\/cancers12071743","article-title":"Y chromosome loss is a frequent event in Barrett's adenocarcinoma and associated with poor outcome","volume":"12","author":"Loeser","year":"2020","journal-title":"Cancers (Basel)"},{"key":"key20240906090918_b22-ol-28-4-14628","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1093\/annonc\/mds640","article-title":"The significance of the HER-2 status in esophageal adenocarcinoma for survival: An immunohistochemical and an in situ hybridization study","volume":"24","author":"Prins","year":"2013","journal-title":"Ann Oncol"},{"key":"key20240906090918_b23-ol-28-4-14628","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s13277-010-0109-6","article-title":"Expressions of hypoxia-inducible factor-1\u03b1 and hexokinase-II in gastric adenocarcinoma: The impact on prognosis and correlation to clinicopathologic features","volume":"32","author":"Qiu","year":"2011","journal-title":"Tumour Biol"},{"key":"key20240906090918_b24-ol-28-4-14628","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1111\/cas.12242","article-title":"Hexokinase II in breast carcinoma: A potent prognostic factor associated with hypoxia-inducible factor-1\u03b1 and Ki-67","volume":"104","author":"Sato-Tadano","year":"2013","journal-title":"Cancer Sci"},{"key":"key20240906090918_b25-ol-28-4-14628","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.annonc.2022.07.003","article-title":"Electronic address: clinicalguidelines@esmo.org: Oesophageal cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"33","author":"Obermannov\u00e1","year":"2022","journal-title":"Ann Oncol"},{"key":"key20240906090918_b26-ol-28-4-14628","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00262-019-02475-w","article-title":"Immune profile and immunosurveillance in treatment-naive and neoadjuvantly treated esophageal adenocarcinoma","volume":"69","author":"Wagener-Ryczek","year":"2020","journal-title":"Cancer Immunol Immunother"},{"key":"key20240906090918_b27-ol-28-4-14628","first-page":"971","article-title":"Expression of hexokinases and glucose transporters in treated and untreated oesophageal adenocarcinoma","volume":"24","author":"Fonteyne","year":"2009","journal-title":"Histol Histopathol"},{"key":"key20240906090918_b28-ol-28-4-14628","first-page":"486","article-title":"Relationship between glucose transporter, hexokinase and FDG-PET in esophageal cancer","volume":"52","author":"Tohma","year":"2005","journal-title":"Hepatogastroenterology"},{"key":"key20240906090918_b29-ol-28-4-14628","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3389\/fonc.2020.00176","article-title":"Regulatory role of hexokinase 2 in modulating head and neck tumorigenesis","volume":"10","author":"Li","year":"2020","journal-title":"Front Oncol"},{"key":"key20240906090918_b30-ol-28-4-14628","doi-asserted-by":"publisher","first-page":"21287","DOI":"10.18632\/oncotarget.7116","article-title":"Long-term prognostic implications and therapeutic target role of hexokinase II in patients with nasopharyngeal carcinoma","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"key20240906090918_b31-ol-28-4-14628","first-page":"837","article-title":"Anticancer properties of capsaicin against human cancer","volume":"36","author":"Clark","year":"2016","journal-title":"Anticancer Res"},{"key":"key20240906090918_b32-ol-28-4-14628","first-page":"6116","article-title":"Capsaicin inhibits glycolysis in esophageal squamous cell carcinoma by regulating hexokinase-2 expression","volume":"17","author":"Mao","year":"2018","journal-title":"Mol Med Rep"},{"key":"key20240906090918_b33-ol-28-4-14628","first-page":"916","article-title":"High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers","volume":"60","author":"Walenta","year":"2000","journal-title":"Cancer Res"},{"key":"key20240906090918_b34-ol-28-4-14628","doi-asserted-by":"publisher","first-page":"610","DOI":"10.3332\/ecancer.2016.680","article-title":"Repurposing drugs in oncology (ReDO)-diclofenac as an anti-cancer agent","volume":"10","author":"Pantziarka","year":"2016","journal-title":"Ecancermedicalscience"},{"key":"key20240906090918_b35-ol-28-4-14628","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1002\/ijc.27712","article-title":"Diclofenac inhibits lactate formation and efficiently counteracts local immune suppression in a murine glioma model","volume":"132","author":"Chirasani","year":"2013","journal-title":"Int J Cancer"},{"key":"key20240906090918_b36-ol-28-4-14628","doi-asserted-by":"publisher","first-page":"715883","DOI":"10.3389\/fcell.2021.715883","article-title":"Comprehensive analysis of hexokinase 2 immune infiltrates and m6A related genes in human esophageal carcinoma","volume":"9","author":"Liu","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"key20240906090918_b37-ol-28-4-14628","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s10238-013-0250-9","article-title":"Association of overexpression of hexokinase II with chemoresistance in epithelial ovarian cancer","volume":"14","author":"Suh","year":"2014","journal-title":"Clin Exp Med"},{"key":"key20240906090918_b38-ol-28-4-14628","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1093\/annonc\/mdn403","article-title":"Biweekly fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) for patients with metastatic adenocarcinoma of the stomach or esophagogastric junction: A phase II trial of the arbeitsgemeinschaft internistische onkologie","volume":"19","author":"Al-Batran","year":"2008","journal-title":"Ann Oncol"},{"key":"key20240906090918_b39-ol-28-4-14628","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1200\/JCO.20.03614","article-title":"Ten-year outcome of neoadjuvant chemoradiotherapy plus surgery for esophageal cancer: The randomized controlled CROSS trial","volume":"39","author":"Eyck","year":"2021","journal-title":"J Clin Oncol"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T02:09:27Z","timestamp":1725588567000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2024.14628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,13]]},"references-count":39,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,8,13]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2024.14628","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,13]]},"article-number":"495"}}